Navigating where to buy PNC-27 peptide for laboratory research requires selecting a verified domestic supplier that guarantees sequence fidelity, high purity, and minimal endotoxin levels. PX1 Research provides USA-manufactured PNC-27 synthesized under strict quality controls for in vitro and preclinical oncology investigations.
Navigating where to buy PNC-27 peptide for laboratory research requires selecting a verified domestic supplier that guarantees sequence fidelity, high purity, and minimal endotoxin levels. PX1 Research provides USA-manufactured PNC-27 synthesized under strict quality controls for in vitro and preclinical oncology investigations.
Qualified academic institutions, biotechnology companies, and independent laboratories seeking where to buy PNC-27 peptide should source directly from ISO-compliant domestic suppliers like PX1 Research. Research-grade PNC-27 must be accompanied by batch-specific documentation verifying structural identity via electrospray ionization mass spectrometry (ESI-MS) and purity exceeding 98% via reverse-phase high-performance liquid chromatography (RP-HPLC). Sourcing from unverified global vendors exposes research projects to non-quantified impurities, incorrect peptide sequences, or severe endotoxin contamination.
When evaluating a vendor for the PNC-27 research peptide, investigators must confirm that the compound is manufactured in GMP-compliant facilities and stored under temperature-monitored conditions. PX1 Research ships all research compounds directly from facilities in California and Arizona with same-day dispatch for orders placed Monday through Friday, ensuring structural stability upon arrival at your facility.
PNC-27 is a synthetic 32-amino-acid chimeric peptide engineered specifically for membrane-active targeted oncology research. The molecule consists of two distinct functional domains: an HDM-2-binding region derived from the p53 tumor suppressor protein (residues 12–26) coupled to a cell-penetrating peptide (CPP) sequence derived from the Antennapedia homeodomain (penetratin).
The complete primary amino acid sequence of PNC-27 is Pro-Pro-Leu-Ser-Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met-Arg-Arg-Asn-Gln-Phe-Trp-Val-Lys-Val-Gln-Arg-Gly. The amphipathic alpha-helical structure created by this fusion allows the peptide to selectively attach to target receptor sites on transformed cell membranes, making it a valuable candidate within the broader catalog of oncolytic research compounds.
Preclinical literature demonstrates that PNC-27 operates through a unique, membrane-directed mechanism. In non-transformed somatic cells, the human double minute 2 (HDM-2) protein is localized predominantly within the nucleus and cytoplasm. However, in a wide variety of cancer cell lines, HDM-2 is aberrantly expressed directly on the outer cell membrane.
In vitro assays show that the p53-derived domain of PNC-27 specifically targets and binds to this membrane-bound HDM-2 protein. Upon binding, the amphipathic transmembrane domain interacts with the lipid bilayer, inducing rapid oligomerization. This structural shift leads to transmembrane pore formation, membrane permeabilization, and subsequent osmotic cell lysis (necrosis) in target tumor cells, while leaving normal, non-transformed cells lacking surface HDM-2 intact.
A critical finding in preclinical studies is that PNC-27 induces tumor cell death independently of the classical intracellular p53 signaling pathway. Traditional p53-targeted therapies rely on functional nuclear p53 to initiate programmed cell death (apoptosis). However, because over 50% of human cancers harbor mutated or deleted p53 genes, traditional apoptotic pathways are frequently bypassed or disabled.
In contrast, experimental data derived from cell culture models—including human pancreatic carcinoma, breast cancer, melanoma, and leukemia lines—indicate that PNC-27 causes rapid physical disruption of the cell membrane regardless of the cell's p53 mutation status. By bypassing intracellular transcription factors and directly attacking membrane integrity, PNC-27 serves as an essential reference model in cancer cell research.
To contextualize the performance of PNC-27 within membrane-active research, investigators frequently compare its activity to other targeted or lytic peptides. For instance, the closely related synthetic peptide PNC-28 shares an identical penetratin domain but contains a slightly modified p53-derived binding sequence (residues 17–26), showing comparable transmembrane pore-forming properties in solid tumor models.
In contrast, non-specific pore-forming molecules such as the human host defense peptide LL-37 disrupt lipid bilayers via general electrostatic interactions rather than receptor-mediated binding. Similarly, experimental tumor-targeting models like P14ARF peptide mechanisms focus on modulating internal cell cycle checkpoints rather than primary cell membrane destruction. Understanding these distinctions allows researchers to design precise comparative assays targeting distinct cell lysis and apoptotic signaling pathways.
Because laboratory data depends entirely on compound purity, sourcing PNC-27 requires rigid supplier verification. Low-grade peptides frequently contain truncated sequences, residual trifluoroacetic acid (TFA) salts, or heavy metal contaminants that skew cellular assays and induce non-specific cytotoxicity.
To guarantee reproducible experimental conditions, researchers should ensure their supplier provides valid, lot-specific analytical documentation. Review the mandatory quality metrics in the selection checklist below:
PNC-27 is supplied as a sterile, lyophilized cake or powder to maintain molecular stability. Upon arrival, the un-reconstituted peptide should be stored in a dry, dark environment at -20°C for short-term preservation or -80°C for long-term storage. Exposure to room temperature should be minimized during initial inventory logging.
For in vitro assay preparation, reconstitute PNC-27 using sterile, bacteriostatic or lab-grade water, or standard phosphate-buffered saline (PBS, pH 7.4), depending on assay compatibility. Gently swirl the vial until the powder dissolves completely; never vortex vigorously, as mechanical shear forces can cause peptide denaturation or aggregation. Aliquot the reconstituted solution into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade the tertiary peptide structure.
Bacterial endotoxins (lipopolysaccharides) pose a significant threat to cell culture validity, particularly when investigating membrane-bound receptor interactions like HDM-2 binding. High endotoxin levels induce non-specific toll-like receptor (TLR) activation, contaminating experimental controls and yielding false data.
At PX1 Research, every batch of PNC-27 undergoes rigorous Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below 0.01 EU/mg. Combined with full-spectrum RP-HPLC analysis performed by independent ISO 17025 accredited laboratories, PX1 Research delivers pure, highly predictable compounds for high-throughput screening and advanced cellular studies. Explore our complete line of verified standards in the all research peptides catalog.
For large-scale screening projects, longitudinal animal studies, or multi-departmental university research projects, consistent batch consistency is critical. PX1 Research offers flexible volume options and dedicated supply pipelines to prevent research interruptions.
Principal investigators and laboratory managers can establish streamlined procurement via wholesale laboratory accounts. Institutional accounts benefit from reserved lot allocation, customized analytical testing protocols, and direct account management to meet strict grant timelines and procurement rules.
Where can I buy PNC-27 peptide for research use?
PNC-27 peptide can be purchased directly through specialized research chemical vendors like PX1 Research. Ensure your chosen vendor provides USA-manufactured compounds with lot-specific Certificate of Analysis (COA) documents confirming ≥ 98% purity.
What is the purity level of PX1 Research PNC-27?
PX1 Research guarantees a minimum analytical purity of 98.0% for PNC-27, verified via reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS).
What receptor target does PNC-27 bind to in preclinical studies?
Preclinical studies show that PNC-27 specifically binds to membrane-bound human double minute 2 (HDM-2) proteins found on the cell membrane of transformed cancer cells.
How should PNC-27 be stored upon delivery?
Lyophilized PNC-27 should be stored at -20°C or -80°C upon receipt. Reconstituted solutions should be aliquoted into single-use vials and stored frozen to avoid freeze-thaw degradation.
Does PNC-27 induce apoptosis or necrosis in target cells?
In vitro research indicates that PNC-27 primary induces rapid cell lysis (necrosis) via transmembrane pore formation, rather than classic apoptosis.
Is PNC-27 effective in p53-deficient cell lines?
Yes, preclinical literature demonstrates that PNC-27 acts independently of the internal p53 signaling pathway, inducing membrane lysis in both p53-wildtype and p53-mutant/deficient tumor lines.
What solvent should be used to reconstitute PNC-27 for cell assays?
PNC-27 is typically reconstituted using sterile laboratory-grade water or phosphate-buffered saline (PBS, pH 7.4), depending on specific cell culture media and protocol requirements.
Does PX1 Research provide endotoxin testing for PNC-27?
Yes, all lots of PNC-27 at PX1 Research undergo LAL endotoxin testing to ensure levels remain below 0.01 EU/mg, preventing background inflammatory interference in cellular models.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.